Our findings demonstrate that in low-MMP conditions, such as glaucoma, the optoenergetic activation of mt-EcGAPR effectively rescues mitochondrial dysfunction by increasing ATP production, inhibiting ROS accumulation, and suppressing ER stress-ATF6-GSDMD axis-mediated pyroptosis (Fig. 8). This evidence concerns the gene ATF6 and glaucoma.